Valeriya graduated from Queen Mary, University of London with a BSc in Biochemistry and a MSc in Neuroscience and Translational Medicine. Her master’s thesis was focused on characterising an orphan GPCR Gpr151 in enteric nervous system using IHC techniques and has recently been submitted to Neuron journal as a part of a broader research study.
Valeriya has since worked in Business Development and Product Management in technology startups in various industries, including education and logistics. Before joining Grey Wolf Therapeutics Ltd, Valeriya completed a project as an Associate at a management & leadership consulting practice, leading the development of an innovative training methodology for senior business leaders of global corporations.
In her role as a Biotech Associate, Valeriya provides key administrative and business support to the CEO and the broader Grey Wolf team.